title: Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients.
abstract: Chronic HIV-1 infection is associated with persistent viremia in most patients, but it remains unclear how free virus may survive the potential hostile effects of plasma. We investigated whether sites might exist on the surfaces of circulating blood cells for protection of infectious HIV-1 particles. Red blood cells (RBC) either from blood of uninfected normal individuals, or from blood obtained without EDTA from chronically infected HIV-1 patients, invariably contained a small number of RBC having attached platelets as determined by flow cytometry, light microscopy, and immunofluorescence microscopy. After mixing normal RBC with platelet-rich plasma, discrete populations of RBC, platelets, and complexes of platelets attached to RBC were purified by fluorescence-activated cell sorting. Upon incubation of purified cells or platelets with HIV-1 followed by washing and co-incubation with CD4-positive peripheral blood mononuclear cells (PBMC), platelets, and platelet-RBC complexes, but not platelet-free RBC, caused infection of PBMC. Infection was prevented by pre-treating the platelet-RBC complexes with EDTA. Plasma and RBC (comprising a RBC/platelet-RBC mixture) from chronically infected patients with low viral loads were also co-incubated with PBMC ex vivo to determine the presence of infectious HIV-1. All freshly isolated plasmas from the HIV-1-infected donors, obtained in the absence of anticoagulant, were noninfectious. Interestingly, the RBC from most of the patients caused cell-cell infection of PBMC that was prevented by stripping the RBC with EDTA. A monoclonal antibody to DC-SIGN partially inhibited cell-cell HIV-1 infection of PBMC by normal RBC pre-incubated with platelets and HIV-1. We conclude: (a) platelet-free EDTA-free plasma from chronically infected HIV-1 patients, although containing viral RNA, is an environment that lacks detectable infectious HIV-1; (b) platelets and platelet-RBC complexes, but not purified RBC, bind infectious HIV-1; (c) DC-SIGN, and possibly other C-type lectins, may represent binding sites for infectious HIV-1 on platelets and platelet-RBC complexes.
authors.affiliation: U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America ; Henry M. Jackson Foundation for the Advancement of Military Medicine, Silver Spring, Maryland, United States of America.
authors.forename: Zoltan
authors.initials: Z
authors.lastname: Beck
authors.forename: Linda L
authors.initials: LL
authors.lastname: Jagodzinski
authors.forename: Michael A
authors.initials: MA
authors.lastname: Eller
authors.forename: Doris
authors.initials: D
authors.lastname: Thelian
authors.forename: Gary R
authors.initials: GR
authors.lastname: Matyas
authors.forename: Anjali N
authors.initials: AN
authors.lastname: Kunz
authors.forename: Carl R
authors.initials: CR
authors.lastname: Alving
mesh_terms: D001792:Blood Platelets / Q000821:virology*; D004912:Erythrocytes / Q000821:virology*; D015658:HIV Infections / Q000097:blood* / Q000821:virology; D015497:HIV-1 / Q000472:pathogenicity / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D008561:Membrane Fusion